Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1/glucagon dual agonist in obesity/diabetes https://www.globenewswire.com/news-release/2020/06/24/2052484/0/en/Zealand-Pharma-announces-first-patient-dosed-in-Phase-2-trial-with-long-acting-GLP-1-glucagon-dual-agonist-in-obesity-diabetes.html company announcement